Search results
Walmart’s $50 Onn 4K Pro is a surprisingly great Google TV streamer | CNN Underscored
CNN.com· 5 hours agoWalmart surprised us with the Onn 4K Pro, a fast and feature-packed Google TV streaming device that...
Will Walmart Reach a Trillion-Dollar Market Cap by 2030?
Motley Fool via Yahoo Finance· 3 days agoMany of them began shopping at Walmart on a regular basis. Given Walmart's current efforts to look...
Gateway - Quartz
Quartz· 11 hours agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
THE FRIDAY 5: Kroger Offering Weight Loss Drugs; Walmart’s Turn to Shelf Labels
Progressive Grocer· 5 days agoPG readers were interested in the opening of Buc-ee's newest and largest travel center to date in...
Dozens of CVS generic drug recalls expose link to tainted factories - The Boston Globe
The Boston Globe· 2 days agoThis potentially dangerous pattern has roots in the quality of the factories from which CVS sources...
Rani Therapeutics (NASDAQ:RANI) Coverage Initiated by Analysts at Rodman & Renshaw
ETF DAILY NEWS· 6 days agoRodman & Renshaw started coverage on shares of Rani Therapeutics (NASDAQ:RANI – Free Report) in a report published on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $10.00 ...
Short Interest in Welcia Holdings Co., Ltd. (OTCMKTS:WLCGF) Expands By 53.7%
ETF DAILY NEWS· 6 days agoWelcia Holdings Co., Ltd. (OTCMKTS:WLCGF – Get Free Report) was the target of a large growth in...
Discount retail chain unveils secret weapon against store theft
TheStreet.com· 7 days agoThe discount chain is undertaking a dramatic new model to prevent the growing issue.
Ozempic is now boosting sales for smaller-sized clothes, fashion executives say
Quartz· 2 days agoIn another ripple effect on the economy, Ozempic and other weight loss drugs are boosting sales of...
Equities Analysts Offer Predictions for Vistagen Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:VTGN)
ETF DAILY NEWS· 5 days agoVistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Vistagen Therapeutics ...